GILEAD SCIENCES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 65.42 USD | +0.23% |
|
-2.01% | -19.24% |
| 04-26 | TD Cowen Adjusts Price Target on Gilead Sciences to $85 From $90 | MT |
| 04-26 | Jefferies Adjusts Gilead Sciences' Price Target to $80 From $95 | MT |
Chart calendar Gilead Sciences, Inc.
667f38e.JqxL00Gpj61DnSXPqOLgYXr8kJdbNIAqU0zmtpSMz30.S-sM4wfbxMdy8x23kI6yJTuZ-8cxWrBAHAaB16y6oQcT5hSyFPH2_i7zUg~08c9243633df637b16bf82e1fcd68547
Upcoming events on Gilead Sciences, Inc.
Past events on Gilead Sciences, Inc.
| 25/04/2024 21:30 | Q1 2024 Earnings Call |
| 25/04/2024 21:02 | Q1 2024 Earnings Release |
| 14/03/2024 14:00 | Investor Meeting |
| 13/03/2024 | Ex-dividend day |
| 13/03/2024 15:15 | Barclays Global Healthcare Conference |
| 12/03/2024 14:00 | Leerink Partners Global Biopharma Conference |
| 05/03/2024 17:50 | TD Cowen Health Care Conference |
| 02/03/2024 | Conference on Retroviruses and Opportunistic Infections |
| 06/02/2024 22:00 | Q4 2023 Earnings Call |
| 06/02/2024 21:02 | Q4 2023 Earnings Release |
| 08/01/2024 18:30 | JPMorgan Healthcare Conference |
| 13/12/2023 | Ex-dividend day |
| 12/12/2023 02:00 | American Society of Hematology Meeting - Abstract Number : 4884 |
| 12/12/2023 02:00 | American Society of Hematology Meeting - Abstract Number : 5101 |
| 12/12/2023 02:00 | American Society of Hematology Meeting - Abstract Number : 4869 |
| 12/12/2023 02:00 | American Society of Hematology Meeting - Abstract Number : 4865 |
| 12/12/2023 02:00 | American Society of Hematology Meeting - Abstract Number : 5100 |
| 12/12/2023 02:00 | American Society of Hematology Meeting - Abstract Number : 4864 |
| 12/12/2023 02:00 | American Society of Hematology Meeting - Abstract Number : 5082 |
| 12/12/2023 02:00 | American Society of Hematology Meeting - Abstract Number : 4424 |
Past dividends on Gilead Sciences, Inc.
| 13/03/2024 | Quarterly 0.77 USD |
| 13/12/2023 | Quarterly 0.75 USD |
| 13/09/2023 | Quarterly 0.75 USD |
| 13/06/2023 | Quarterly 0.75 USD |
| 13/03/2023 | Quarterly 0.75 USD |
| 13/12/2022 | Quarterly 0.73 USD |
| 13/09/2022 | Quarterly 0.73 USD |
| 13/06/2022 | Quarterly 0.73 USD |
| 13/03/2022 | Quarterly 0.73 USD |
| 13/12/2021 | Quarterly 0.71 USD |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 22 449 22 305 0.65% | 24 689 24 482 0.84% | 27 305 26 657 2.43% | 27 281 26 518 2.88% | 27 116 27 083 0.12% | 27 548 |
|
EBITDA Million USD | Released Forecast Spread | 12 468 13 029 -4.3% | 13 184 13 142 0.32% | 14 598 15 539 -6.05% | 14 283 13 783 3.63% | 13 177 13 123 0.41% | 9 521 |
|
EBIT Million USD | Released Forecast Spread | 11 064 11 571 -4.38% | 11 704 11 599 0.9% | 12 548 13 943 -10.01% | 12 180 12 141 0.32% | 10 484 10 687 -1.9% | 7 324 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 5 160 5 333 -3.24% | 1 669 1 636 2.01% | 8 278 9 507 -12.92% | 5 814 5 658 2.76% | 6 859 7 323 -6.33% | 1 487 |
|
Net income Million USD | Released Forecast Spread | 5 386 4 292 25.5% | 123 137 -10.03% | 6 225 7 205 -13.6% | 4 592 4 383 4.77% | 5 665 5 872 -3.52% | 437 |
|
EPS USD | Released Forecast Spread | 4,22 3,43 23.14% | 0,10 0,12 -16.23% | 4,93 5,75 -14.19% | 3,64 3,48 4.75% | 4,50 4,69 -3.96% | 0,47 |
| Announcement Date | 04/02/20 | 04/02/21 | 01/02/22 | 02/02/23 | 06/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 7 244 6 615 9.51% | 6 590 6 279 4.96% | 6 260 5 873 6.6% | 7 042 6 133 14.82% | 7 389 6 630 11.45% | 6 352 6 326 0.41% | 6 599 6 454 2.24% | 7 051 6 800 3.69% | 7 115 7 104 0.16% | 6 686 6 349 5.31% | 6 729 | 6 991 | 7 247 | 6 487 |
|
EBITDA Million USD | Released Forecast Spread | 2 042 3 449 -40.79% | 4 049 3 438 17.79% | 3 195 3 183 0.38% | 3 811 3 049 24.99% | 3 227 2 865 12.63% | 2 883 3 407 -15.38% | 3 258 3 343 -2.54% | 3 908 3 636 7.49% | 3 427 3 495 -1.94% | -889 | 3 349 | 3 384 | 3 555 | |
|
EBIT Million USD | Released Forecast Spread | 1 507 2 905 -48.13% | 3 524 3 060 15.15% | 2 670 2 602 2.6% | 3 286 2 529 29.91% | 2 699 2 622 2.92% | 2 243 2 658 -15.62% | 2 277 2 776 -17.99% | 3 224 3 060 5.37% | 2 739 2 940 -6.84% | -1 117 -1 679 33.48% | 2 675 | 2 893 | 2 912 | 2 605 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 759 1 966 -61.4% | -152 2 158 -107.05% | 1 503 1 664 -9.68% | 2 432 1 674 45.28% | 2 031 1 840 10.37% | 1 300 1 900 -31.59% | 1 588 1 969 -19.35% | 2 318 2 275 1.91% | 1 653 2 090 -20.89% | -4 486 | 1 796 | 2 215 | 2 170 | 2 025 |
|
Net income Million USD | Released Forecast Spread | 382 1 424 -73.17% | 19,0 1 611 -98.82% | 1 144 1 367 -16.32% | 1 789 1 248 43.39% | 1 640 1 438 14.02% | 1 010 1 587 -36.37% | 1 045 1 545 -32.38% | 2 180 1 801 21.07% | 1 429 1 599 -10.66% | -4 170 -2 888 -44.38% | 1 444 | 1 654 | 1 634 | 1 562 |
|
EPS USD | Released Forecast Spread | 0,30 1,14 -73.64% | 0,02 1,34 -98.5% | 0,91 1,11 -17.89% | 1,42 1,01 40.93% | 1,30 1,15 13% | 0,80 1,23 -34.75% | 0,83 1,20 -30.93% | 1,73 1,43 20.88% | 1,14 1,28 -11.05% | -3,34 -1,92 -74.06% | 1,14 | 1,29 | 1,30 | 1,16 |
| Announcement Date | 01/02/22 | 28/04/22 | 02/08/22 | 27/10/22 | 02/02/23 | 27/04/23 | 03/08/23 | 07/11/23 | 06/02/24 | 25/04/24 | - | - | - | - |
More events
Past sector events for Gilead Sciences, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- GILD Stock
- Calendar Gilead Sciences, Inc.
